Annual SG&A:
$43.75M+$8.24M(+23.22%)Summary
- As of today, TNGX annual SG&A is $43.75 million, with the most recent change of +$8.24 million (+23.22%) on December 31, 2024.
- During the last 3 years, TNGX annual SG&A has risen by +$26.15 million (+148.61%).
- TNGX annual SG&A is now at all-time high.
Performance
TNGX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$11.34M(-100.00%)Summary
- As of today, TNGX quarterly SG&A is $0.00, with the most recent change of -$11.34 million (-100.00%) on September 30, 2025.
- Over the past year, TNGX quarterly SG&A has dropped by -$11.22 million (-100.00%).
- TNGX quarterly SG&A is now -100.00% below its all-time high of $11.48 million, reached on March 31, 2025.
Performance
TNGX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$2.19B-$100.52M(-4.82%)Summary
- As of today, TNGX TTM SG&A is -$2.19 billion, with the most recent change of -$100.52 million (-4.82%) on September 30, 2025.
- Over the past year, TNGX TTM SG&A has dropped by -$2.23 billion (-5338.58%).
- TNGX TTM SG&A is now -437536300.00% below its all-time high of -$500.00.
Performance
TNGX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
TNGX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +23.2% | -100.0% | -5338.6% |
| 3Y3 Years | +148.6% | -100.0% | -7856.6% |
| 5Y5 Years | +343.4% | -100.0% | -10000.0% |
TNGX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +148.6% | -100.0% | at low | -173.6% | at low |
| 5Y | 5-Year | at high | +343.4% | -100.0% | at low | >-9999.0% | at low |
| All-Time | All-Time | at high | +343.4% | -100.0% | at low | >-9999.0% | at low |
TNGX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $33.91M(-24.9%) |
| Jun 2025 | - | $11.34M(-1.2%) | $45.13M(+1.3%) |
| Mar 2025 | - | $11.48M(+3.5%) | $44.56M(+1.9%) |
| Dec 2024 | $43.75M(+23.2%) | $11.09M(-1.2%) | $43.75M(+4.8%) |
| Sep 2024 | - | $11.22M(+4.2%) | $41.76M(+5.1%) |
| Jun 2024 | - | $10.77M(+1.1%) | $39.75M(+4.2%) |
| Mar 2024 | - | $10.66M(+17.1%) | $38.15M(+7.5%) |
| Dec 2023 | $35.50M(+18.2%) | $9.11M(-1.1%) | $35.50M(+3.6%) |
| Sep 2023 | - | $9.21M(+0.4%) | $34.28M(+3.3%) |
| Jun 2023 | - | $9.17M(+14.5%) | $33.17M(+6.2%) |
| Mar 2023 | - | $8.01M(+1.6%) | $31.23M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $30.02M(+70.6%) | $7.89M(-2.6%) | $30.02M(+6.5%) |
| Sep 2022 | - | $8.10M(+12.0%) | $28.20M(+14.9%) |
| Jun 2022 | - | $7.23M(+6.2%) | $24.54M(+17.2%) |
| Mar 2022 | - | $6.81M(+12.2%) | $20.94M(+19.0%) |
| Dec 2021 | $17.60M(+78.4%) | $6.07M(+36.8%) | $17.60M(+21.0%) |
| Sep 2021 | - | $4.43M(+22.1%) | $14.55M(+15.2%) |
| Jun 2021 | - | $3.63M(+4.7%) | $12.63M(+40.3%) |
| Mar 2021 | - | $3.47M(+15.0%) | $9.00M(+62.6%) |
| Dec 2020 | $9.87M | $3.02M(+19.8%) | $5.53M(+119.8%) |
| Sep 2020 | - | $2.52M(>+9900.0%) | $2.52M(>+9900.0%) |
| Jun 2020 | - | $500.00 | $500.00 |
FAQ
- What is Tango Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. annual SG&A year-on-year change?
- What is Tango Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Tango Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. TTM SG&A year-on-year change?
What is Tango Therapeutics, Inc. annual SG&A?
The current annual SG&A of TNGX is $43.75M
What is the all-time high annual SG&A for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high annual SG&A is $43.75M
What is Tango Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, TNGX annual SG&A has changed by +$8.24M (+23.22%)
What is Tango Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of TNGX is $0.00
What is the all-time high quarterly SG&A for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high quarterly SG&A is $11.48M
What is Tango Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, TNGX quarterly SG&A has changed by -$11.22M (-100.00%)
What is Tango Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of TNGX is -$2.19B
What is the all-time high TTM SG&A for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high TTM SG&A is -$500.00
What is Tango Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, TNGX TTM SG&A has changed by -$2.23B (-5338.58%)